IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025
- Written by PR Newswire
 |
- Showcased end-to-end, customized manufacturing capabilities covering vaccines, gene and immune therapeutics
- Strengthening global CDMO strategy through strategic synergy with SK bioscience
- Sustainable growth expected, backed by European commercial manufacturing infrastructure and regulatory expertise
FRANKFURT, Germany, VIENNA and SEONGNAM, South Korea...
